Tickerplace logo

Tickerplace

Cytokinetics, Incorporated logo

CYTKCytokinetics, Incorporated

CYTK Stock Price, Valuation & Chart | Cytokinetics, Incorporated

Compare
$61.950-1.97 (-3.08%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

CYTK Historical price chart

CYTK Key Stats

Market Capitalization8.61B
PE Ratio-8.58
EPS-7.22
Trading Volume1.20M
Today's High/Low63.9/61.69
Dividend Yield0.00
52 Week High/Low88.31/54.3
Shares Outstanding139.02M
CYTK Financial Statement
CYTK Analyst ratings
CYTK Analysis & performance metrics

CYTK Company profile

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential…

CYTK Management team

Management
Robert I. BlumCEO
Chief Executive Officer, President & Director
Sung H. LeeCFO
EVice President & Chief Financial Officer
Matt Yang
Vice President of Corporate Finance and Financial Planning & Analysis
Holly Laughlin
Vice President of Accounting & Corporate Controller
Kari K. Loeser J.D.
Vice President & Chief Compliance Officer
Andrew M. Callos
Executive Vice President & Chief Commercial Officer
Steven M. Cook J.D.
Senior Vice President of Global Supply Chain Operations & Technical Operations
Jeff Lotz
Vice President of Sales & Operations
Total 8 executives

CYTK Frequently asked questions

What is Cytokinetics, Incorporated (CYTK) Stock Price?

Current stock price of Cytokinetics, Incorporated (CYTK) stock is $61.950. The stock price is -3.08% lower in the session. The intraday range can be seen from this page. Volume of Cytokinetics, Incorporated (CYTK) stock is 1.20M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Cytokinetics, Incorporated (CYTK) stock price going up or down today?

The stock price of Cytokinetics, Incorporated (CYTK) can change with earnings, company news, and overall market sentiment. Cytokinetics, Incorporated operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cytokinetics, Incorporated stock expensive at its current price?

Whether Cytokinetics, Incorporated looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CYTK on this page is -8.58. EPS on this page is -7.22. Compare those figures with peers and growth expectations before deciding if the current Cytokinetics, Incorporated price is justified.

How has the stock price of Cytokinetics, Incorporated (CYTK) performed historically?

Historical performance for Cytokinetics, Incorporated (CYTK) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CYTK reacted to past earnings and market events.

Should I buy Cytokinetics, Incorporated (CYTK) stock, at this price?

Buying Cytokinetics, Incorporated (CYTK) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.